Chemotherapy Market Forecast Highlights Expansion From $41.95 Billion To $68.43 Billion Through 2030
Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.
Chemotherapy Market Expansion From $41.95 Billion In 2026 To $68.43 Billion In 2030
Over recent years, the chemotherapy market has undergone a rapid expansion in size, with its value projected to rise from $37.27 billion in 2025 to $41.95 billion in 2026, reflecting a compound annual growth rate (CAGR) of 12.5%. This historical growth was driven by factors including a higher incidence of cancer cases, growing government spending on healthcare services, progress in the development of chemotherapeutic drugs, improvements in hospital facilities, and the increased use of intravenous chemotherapy treatments.
The size of the chemotherapy market is forecasted to expand quickly over the coming years. By 2030, its value is projected to reach $68.44 billion, reflecting a compound annual growth rate (CAGR) of 13.0%. This anticipated growth during the forecast period stems from the broadening scope of precision medicine, progress in creating targeted therapies, heightened awareness of home-based chemotherapy options, the incorporation of digital health tools, and a growing preference for combination treatments. Key developments shaping the period include the rise of individualized chemotherapy schedules, an increased uptake of oral chemotherapeutic agents, the advancement of combination drug therapies, the provision of chemotherapy in home settings, and the evolution of sophisticated infusion device technologies.
Download A Free Sample Report For Comprehensive Market Insights:
Chemotherapy Market Expansion Drivers: What Is Shaping Future Growth?
Rising rates of cancer are anticipated to accelerate the expansion of the chemotherapy market in the coming period. This condition occurs when abnormal body cells multiply without control and invade other tissues. Treatment involves the use of potent chemicals, either alone or in combination, aimed at destroying rapidly dividing cancer cells. As cancer becomes more common, the need for chemotherapy treatments grows accordingly. Data from the World Health Organization, a United Nations agency headquartered in Switzerland, released in February 2024, projects that by 2025 there will be over 35 million new cancer diagnoses, representing a 77% surge compared to the approximately 20 million cases estimated for 2022. Consequently, the upward trend in cancer prevalence is fueling demand within the chemotherapy sector.
Chemotherapy Market Segment Landscape And Growth Potential
The chemotherapy market covered in this report is segmented –
1) By Product Type: Pump, Cannula, Catheter, Other Product Types
2) By Service: Blood Cancer, Throat Cancer, Lung Cancer, Ovarian Cancer, Stomach Cancer
3) By Drugs: Alkylating Agents, Antimetabolites, Anti-Tumor Antibiotics, Topoisomerase Inhibitors, Mitotic Inhibitors, Other Drugs
4) By Route Of Administration: Oral, Intravenous
5) By End User: Hospitals, Research Institutes, Other End Users
Subsegments:
1) By Pump: Infusion Pumps, Portable Pumps, Ambulatory Pumps
2) By Cannula: Peripheral Cannulas, Central Venous Catheters, Implantable Ports
3) By Catheter: Chemotherapy Catheters, PICC Lines
4) By Other Product Types: Safety Devices, IV Sets, Administration Sets
Chemotherapy Market Strategic Trends: What Is Defining The Next Phase Of Growth?
Leading market players within the chemotherapy sector are actively pursuing strategic collaborations to facilitate the commercial rollout of advanced medical devices designed to enhance chemotherapy services. These alliances are crafted to combine the distinct capabilities and resources of each entity, aiming to expedite advancements in cancer care, elevate patient outcomes, and tackle unmet therapeutic needs. A case in point occurred in March 2023 when EVERSANA, a US-based life sciences service provider, joined forces with ChemoMouthpiece LLC, an American medical device firm, to back the market introduction and commercialization of the Chemo Mouthpiece, a device intended to aid oncology patients nationwide. This intraoral ice pack administers cryotherapy to the oral cavity of individuals undergoing chemotherapy, serving to both prevent and treat oral mucositis, a frequent and severe side effect of the treatment.
Chemotherapy Market Competitive Landscape: Who Are The Leading Companies?
Major companies operating in the chemotherapy market are GlaxoSmithKline plc, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Novartis AG, Pfizer Inc., Merck & Co Inc., Sanofi SA, Celgene Corporation, Bristol-Myers Squibb Company, Amgen Inc., Bayer AG, Almatic Pharma LLC, AstraZeneca Pharmaceuticals, Astellas Pharma Inc., Puma Biotechnology Inc., Clovis Oncology Inc., Takeda Pharmaceutical Company Limited, Johnson & Johnson Services Inc., Mylan NV, Teva Pharmaceutical Industries Ltd., AbbVie Inc., Gilead Sciences Inc., Biogen Inc., Eisai Co. Ltd., Ipsen SA, Spectrum Pharmaceuticals Inc., Seattle Genetics Inc., Exelixis Inc., Karyopharm Therapeutics Inc., Incyte Corporation, Agios Pharmaceuticals Inc., Epizyme Inc., Blueprint Medicines Corporation, Array BioPharma Inc., BeiGene Ltd., Halozyme Therapeutics Inc., MacroGenics Inc., Immunomedics Inc., TG Therapeutics Inc., Verastem Inc.
Access The Complete Chemotherapy Market Report:
Chemotherapy Market Regional Distribution: Which Areas Drive Market Expansion?
North America was the largest region in the chemotherapy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the chemotherapy market report during the forecast period. The regions covered in the chemotherapy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
